Implications, Money, NeuroPsyche

SPECIAL REPORT: Marketing a Phony “Miracle” Drug – (Rolling Stone)

Eli Lilly insists that it has not marketed Zyprexa off-label and that it has
accurately represented the drug’s side effects. But some medical researchers who
have studied the atypical antipsychotics say that, in the final tally, the
drugs, which have already been linked to some deaths, may eventually be
responsible for tens of thousands of cases of diabetes and other potentially
fatal diseases. And despite their early promise for treating schizophrenia, the
drugs have not even performed any better than the crude and imprecise earlier
medications that preceded them. …